You are conducting an experiment on mitochondrial respiration. You add malate/pyruvate and respiration is normal. You add succinate and respiration is normal. When you add another substance in the presence of pyruvate/succinate and malate, respiration is blocked. Which of the following substances is most likely added?

Explanation

## Correct Answer: B. Oligomycin Oligomycin is an ATP synthase inhibitor that blocks the phosphorylation step of oxidative phosphorylation without affecting the electron transport chain (ETC) itself. The key discriminator in this question is that malate/pyruvate and succinate both support normal respiration *independently*, meaning electrons are flowing through the ETC normally via Complex I (malate/pyruvate) and Complex II (succinate). When oligomycin is added, it blocks ATP synthase (Complex V), preventing the proton gradient from being used to generate ATP. This causes the proton gradient to build up, which back-inhibits the ETC, halting electron transport and thus blocking respiration. The critical insight is that oligomycin does NOT directly inhibit any ETC complex—it works downstream by preventing proton gradient dissipation. Since the ETC complexes themselves remain functional (as evidenced by normal respiration with each substrate alone), the block must occur at the ATP synthase level. This is why respiration ceases: without ATP synthesis, the proton-motive force accumulates, creating a "traffic jam" that stops the entire chain. [cite: Harper Biochemistry Ch. 12; KD Tripathi Pharmacology Ch. 8] ## Why the other options are wrong **A. Rotenone** — Rotenone is a Complex I inhibitor that blocks NADH oxidation. If rotenone were added, malate/pyruvate respiration would already be blocked (since malate feeds electrons via Complex I through NADH). The question states respiration is normal with malate/pyruvate alone, so rotenone cannot be the added substance. This is the NBE trap—students may confuse rotenone's site of action with oligomycin's. **C. Antimycin A** — Antimycin A inhibits Complex III (cytochrome bc1 complex), blocking electron transfer from ubiquinol to cytochrome c. If antimycin A were present, both malate/pyruvate and succinate respiration would be blocked immediately, since both pathways converge at Complex III. The question shows both substrates support normal respiration, ruling out antimycin A. **D. 2,4-dinitrophenol** — 2,4-DNP is an uncoupler that dissipates the proton gradient without producing ATP, causing heat generation instead. If 2,4-DNP were added, respiration would *increase* (not block), as the ETC would run faster to try to rebuild the gradient. The question explicitly states respiration is blocked, making 2,4-DNP incompatible with the observed outcome. ## High-Yield Facts - **Oligomycin** blocks ATP synthase (Complex V) and causes back-inhibition of the ETC by allowing proton gradient accumulation. - **Rotenone** (Complex I inhibitor) blocks NADH-dependent respiration but not succinate-dependent respiration. - **Antimycin A** (Complex III inhibitor) blocks both NADH and succinate oxidation since both converge at Complex III. - **2,4-DNP** (uncoupler) increases O₂ consumption and heat production by dissipating the proton gradient without ATP synthesis. - The **proton-motive force** (Δμ) drives ATP synthesis; oligomycin prevents its dissipation, causing ETC shutdown via back-pressure. ## Mnemonics **ETC Inhibitor Sites (RACA)** **R**otenone (Complex I) → **A**ntimycin A (Complex III) → **C**yanide (Complex IV) → **A**TP synthase (Complex V). Oligomycin hits ATP synthase, not the chain itself. **Oligomycin = Proton Pump Blocker** Oligomycin blocks ATP synthase → protons accumulate → gradient backs up → ETC stalls. Think 'traffic jam'—the road (ETC) is fine, but the exit (ATP synthase) is closed. ## NBE Trap NBE pairs oligomycin with "respiration blocked" to trap students who confuse it with direct ETC inhibitors (rotenone, antimycin A, cyanide). The key is recognizing that oligomycin works *downstream* of the ETC via back-inhibition, not by directly poisoning an ETC complex. ## Clinical Pearl In Indian clinical practice, oligomycin is not used therapeutically, but understanding its mechanism is critical for recognizing mitochondrial dysfunction in sepsis and metabolic acidosis—conditions where impaired ATP synthesis and back-inhibition of the ETC contribute to organ failure. _Reference: Harper Biochemistry Ch. 12 (Oxidative Phosphorylation); KD Tripathi Pharmacology Ch. 8 (Mitochondrial Toxins)_